VIZIMPRO Trademark

Trademark Overview

On Wednesday, December 8, 2010, a trademark application was filed for VIZIMPRO with the United States Patent and Trademark Office. The USPTO has given the VIZIMPRO trademark a serial number of 85979594. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, April 4, 2024. This trademark is owned by Pfizer Inc.. The VIZIMPRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological diseases and disorders
vizimpro

General Information

Serial Number85979594
Word MarkVIZIMPRO
Filing DateWednesday, December 8, 2010
Status800 - REGISTERED AND RENEWED
Status DateThursday, April 4, 2024
Registration Number4401809
Registration DateTuesday, September 10, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 13, 2010
Primary Code005
First Use Anywhere DateThursday, March 21, 2013
First Use In Commerce DateThursday, March 21, 2013

Trademark Owner History

Party NamePF PRISM C.V.
Party Type31 - New Owner After Registration
Legal Entity Type13 - Limited Partnership
Addressaan den IJssel 2909 LD
NL
Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Thursday, April 4, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, April 4, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, April 4, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, April 3, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, March 14, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Thursday, March 14, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 5, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, September 10, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, September 8, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, September 8, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, September 7, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 29, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, September 10, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 22, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 10, 2013REGISTERED-PRINCIPAL REGISTER
Thursday, August 8, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 7, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, August 6, 2013ASSIGNED TO LIE
Wednesday, July 24, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 3, 2013STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 27, 2013USE AMENDMENT FILED
Wednesday, July 3, 2013DIVISIONAL PROCESSING COMPLETE
Thursday, June 27, 2013DIVISIONAL REQUEST RECEIVED
Thursday, June 27, 2013TEAS REQUEST TO DIVIDE RECEIVED
Thursday, June 27, 2013TEAS STATEMENT OF USE RECEIVED
Thursday, June 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 5, 2013SOU EXTENSION 4 GRANTED
Wednesday, May 22, 2013SOU EXTENSION 4 FILED
Wednesday, May 22, 2013SOU TEAS EXTENSION RECEIVED
Saturday, January 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 11, 2013SOU EXTENSION 3 GRANTED
Thursday, December 13, 2012SOU EXTENSION 3 FILED
Thursday, December 13, 2012SOU TEAS EXTENSION RECEIVED
Thursday, July 19, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 18, 2012SOU EXTENSION 2 GRANTED
Thursday, June 14, 2012SOU EXTENSION 2 FILED
Friday, July 13, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 19, 2012SOU TEAS EXTENSION RECEIVED
Tuesday, June 19, 2012NOTICE OF REVIVAL - E-MAILED
Tuesday, June 19, 2012SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, June 19, 2012PETITION TO REVIVE-GRANTED
Tuesday, June 19, 2012TEAS PETITION TO REVIVE RECEIVED
Thursday, December 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 13, 2011SOU EXTENSION 1 GRANTED
Tuesday, December 13, 2011SOU EXTENSION 1 FILED
Tuesday, December 13, 2011SOU TEAS EXTENSION RECEIVED
Tuesday, June 14, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2011PUBLISHED FOR OPPOSITION
Thursday, March 10, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 9, 2011ASSIGNED TO EXAMINER
Monday, December 13, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 11, 2010NEW APPLICATION ENTERED

Related Keywords

vizimpro diseases disorders oncological treatment preparations pharmaceutical